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Mitochondria import a large number of nuclear-en-
coded proteins via membrane-bound transport
machineries; however, little is known about regula-
tion of the preprotein translocases. We report that
the main protein entry gate of mitochondria, the
translocase of the outer membrane (TOM complex),
is phosphorylated by cytosolic kinases—in partic-
ular, casein kinase 2 (CK2) and protein kinase
A (PKA). CK2 promotes biogenesis of the TOM
complex by phosphorylation of two key compo-
nents, the receptor Tom22 and the import protein
Mim1, which in turn are required for import of further
Tom proteins. Inactivation of CK2 decreases the
levels of the TOM complex and thus mitochondrial
protein import. PKA phosphorylates Tom70 under
nonrespiring conditions, thereby inhibiting its
receptor activity and the import of mitochondrial
metabolite carriers. We conclude that cytosolic
kinases exert stimulatory and inhibitory effects on
biogenesis and function of the TOM complex and
thus regulate protein import into mitochondria.
INTRODUCTION
Mitochondria play crucial roles in cellular energy conversion,
numerous metabolic pathways, maintenance of ion concentra-
tions, and regulation of apoptosis. Proteomic studies indicate
that mitochondria contain 1000 (yeast) to 1500 (human)
different proteins, 99% of which are being encoded by nuclear
genes and synthesized as precursors on cytosolic ribosomes
(Mootha et al., 2003; Neupert and Herrmann, 2007; Pagliarini
et al., 2008; Chacinska et al., 2009). The central entry gate forvirtually all nuclear-encodedmitochondrial proteins is theprepro-
tein translocase of the outer membrane (TOM complex). The
receptors Tom20 and Tom70 initially recognize the precursor
proteins: Tom20preferentially preproteinswithN-terminal prese-
quences, and Tom70 hydrophobic precursors with internal tar-
geting signals (Young et al., 2003; Dolezal et al., 2006; Neupert
and Herrmann, 2007). Upon interaction with the initial receptors,
the precursors are transferred to the central receptor Tom22 and
from here to the import channel Tom40 (Neupert and Herrmann,
2007;Chacinska et al., 2009). Three small Tomproteinsmodulate
the assembly and stability of the TOM complex. After passing
through the TOM complex, the precursor proteins use different
machineries to reach their functional destination in the four mito-
chondrial subcompartments: outer membrane, intermembrane
space, innermembrane, andmatrix (Dolezal et al., 2006; Neupert
and Herrmann, 2007; Chacinska et al., 2009).
Little is known about regulation of the translocases that
mediate preprotein import into mitochondria. Reversible phos-
phorylation of proteins is a major means of regulation of cellular
processes. Studies in recent years indicated that the number of
mitochondrial phosphoproteins is larger than expected (Chi
et al., 2007; Li et al., 2007; Reinders et al., 2007; Albuquerque
et al., 2008; Gnad et al., 2009; Holt et al., 2009). The functional
consequences of phosphorylation, however, have only been
investigated for a limited set of mitochondrial proteins, including
regulation of apoptotic processes, mitochondrial morphology,
pyruvate dehydrogenase, and respiratory complexes; phos-
phorylation of a few preproteins was shown to modulate their
interaction with Hsp70 chaperones and transfer into mitochon-
dria (Desagher et al., 2001; Robin et al., 2003; Pagliarini and
Dixon, 2006; de Rasmo et al., 2008; Soubannier and McBride,
2009). Large-scale studies of phosphoproteins in baker’s yeast
indicated the existence of phosphorylation sites on the translo-
cases of the mitochondrial membranes (Chi et al., 2007; Li
et al., 2007; Albuquerque et al., 2008; Gnad et al., 2009; Holt
et al., 2009); however, it has not been reported so far whetherCell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc. 227
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Figure 1. Phosphorylation of TOM Recep-
tors by CK2 and PKA
(A) Phosphorylation of purified TOM subunits with
recombinant kinases, analyzed by SDS-PAGE and
autoradiography. Kinase autophosphorylation
bands are indicated (CK2a, CK2b, and GSK3).
(B) Phosphorylation of Tom22cd phosphosite
mutants. In samples 5–16, the applied kinase
activity represented 50% for CK1 and 10% for
CK2 of the one applied in (A) and samples 1–4.WT,
wild-type.
(C) In vitro phosphorylation of Tom20cd phospho-
site mutants.
(D) In vitro phosphorylation of Tom70cd phospho-
site mutants.
See also Table S1 and Figure S1.any of these phosphosites are of functional relevance. Thus,
despite our detailed knowledge about composition and function
of the preprotein translocases, posttranslational regulatory
mechanisms acting at the membrane translocases of mitochon-
dria have not been identified.
Here, we report that biogenesis and function of the TOM
complex are regulated by protein kinases. Yeast mutant cells
of casein kinase 2 (protein kinase CK2) show severe defects in
the levels of the TOMcomplex. CK2 phosphorylates the receptor
Tom22 and the mitochondrial import protein Mim1 that are crit-
ical for the biogenesis of further TOM subunits. Whereas CK2
plays a stimulatory role for mitochondrial biogenesis, protein
kinase A (PKA) plays an inhibitory role. PKA phosphorylates
the receptor Tom70 and thus impairs its activity for the import
of metabolite carriers of the inner-mitochondrial membrane.
Our study reveals that the main protein entry gate of mitochon-
dria is not a static complex but is regulated by cytosolic kinases.
RESULTS
Phosphorylation of Tom Proteins by Cytosolic Kinases
In Vitro
To map phosphorylation sites on the TOM complex, we purified
Saccharomyces cerevisiaemitochondria, outer-membrane vesi-228 Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc.cles, and TOMcomplex (Figure S1A avail-
able online). Phosphopeptides were en-
riched and analyzed by tandem mass
spectrometry (MS/MS). We identified 30
phosphosites in Tom proteins. Ten sites
agreed with previously determined sites
(Chi et al., 2007; Li et al., 2007; Albuquer-
que et al., 2008; Gnad et al., 2009; Holt
et al., 2009), and we identify 20 additional
sites, leading to a total of 31 TOM phos-
phosites (Table S1 and Figure S1B). All
Tom proteins were phosphorylated
(including Tom71, a low-abundant iso-
form of Tom70). Most phosphosites
were located on the cytosolic side of theouter membrane, particularly in the cytosolic domains of the
receptors Tom20, Tom22, Tom70, and Tom71 (Figure S1B).
Prediction of potential kinases for the TOM phosphosites
yielded several cytosolic kinases—in particular, CK2 and PKA
(Figure S1B). We performed an in vitro screen using recombi-
nantly expressed TOM subunits, [g-33P]ATP, and the purified
kinases CK2, CK1, PKA, calmodulin-dependent kinase II (Cam-
KII), p42 mitogen-activated protein kinase (MAPK), cyclin-
dependent kinase 1 (CDK1)-cyclin B complex, CDK2-cyclin
A complex, and glycogen synthase kinase 3 (GSK3) (Figure 1A).
Purified TOM subunits included the cytosolic domains of the
receptors Tom22cd, Tom20cd, and Tom70cd; Tom40 renatured
from inclusion bodies; and the cytosolic domain of Tom6 fused
to glutathione S-transferase (GST).
Tom22cd was phosphorylated by the acidophilic kinases CK1
and CK2 (Figure 1A and Figure S1C). Ser44 and Ser46 of Tom22
match the CK2 consensus sequence (Meggio and Pinna, 2003).
Replacement of Ser44 and Ser46 by alanines strongly reduced
phosphorylation of Tom22cd by CK2 (Figure 1B). We generated
an antiserum that selectively recognized phospho-Ser46 of
Tom22 (Figure S1D). Comparison of the phosphorylation by CK1
and CK2 using lower kinase concentrations revealed that CK2
functions asmajor kinase for Tom22 (Figure 1B, right). In addition,
Tom22cdwasweakly phosphorylatedbyPKAat Thr76 (Figure 1B).
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Figure 2. Inactivation of CK2 in Yeast Causes Depletion of Mitochondrial TOM Complexes
(A) WT and ck2-ts yeast were grown at 24C and shifted to 37C for 12–24 hr. Mitochondria or whole-cell extracts were analyzed by SDS-PAGE and
immunoblotting. Parental, parental strain (YPH250) to ck2-ts and WT; mg, mitochondrial protein.
(B) Blue native electrophoresis and immunoblot analysis of the TOM complex from WT and ck2-ts mitochondria.
(C) Blue native electrophoresis and immunoblot analysis of the respiratory chain complexes III, IV, and V.Tom20cd was mainly phosphorylated by CK2 and only weakly
by several further kinases (Figure 1A and Figure S1C). Ser172
was the critical residue for thephosphorylationbyCK2 (Figure1C).
Western blot analysis with an antiserum recognizing phospho-
Ser172 confirmedphosphorylation of Tom20byCK2 (FigureS1E).
Tom70cd was preferentially phosphorylated by PKA (Figure 1A).
Mutant analysis revealed that Ser174 was the target residue for
PKA, whereas the weak phosphorylation by CK1, GSK3, or Cam-
KII was not altered in the mutant proteins analyzed (Figure 1D).
Tom40wasphosphorylatedbyseveral kinases invitro, including
CK1, PKA (Ser54), and MAPK (Figure 1A and Figure S1F). Tom6
was phosphorylated on Ser16 by the cyclin-dependent kinase
complexes, CDK1-cyclin B and CDK2-cyclin A (Figure S1G).
These results indicate that purified Tom proteins can be phos-
phorylated by cytosolic kinases in vitro. The three receptors were
found to be major targets for CK2 (Tom22 and Tom20) and PKA
(Tom70), respectively.
Inactivation of CK2 Leads to Defects
of the Mitochondrial TOM Complex In Vivo
ToaskwhetherCK2exerted aneffect on the TOMcomplex in vivo,
we used ck2mutant yeast cells. Yeast CK2 consists of two cata-
lytic a subunits, Cka1 and Cka2, and two regulatory b subunits,
Ckb1 and Ckb2 (Poole et al., 2005). Because the activity of CK2
isessential for yeast viability,weemployed the temperature-sensi-
tive mutant strain ck2-ts, in which CKA1 and CKA2 have been
deleted and a conditional allele of CKA2 is expressed from
a plasmid (Hanna et al., 1995). When ck2-ts cells were grown atpermissive temperature (24C), the levels of mitochondrial
proteins were in the wild-type (WT) range (Figure 2A). Upon shift
to nonpermissive conditions (37C), the levels of TOM subunits
decreased. After a 12 hr shift, in particular, the levels of Tom22
and Tom20 were reduced, and after a 24 hr shift, the levels of all
TOM subunits analyzed were severely reduced (Figure 2A). The
levels of further mitochondrial proteins tested were not or were
only partially reduced after the 24 hr shift. Proteins of the cytosol
and endoplasmic reticulum (ER) analyzed were not reduced in
ck2-ts cells compared to wild-type cells after the 24 hr shift,
including phosphoglycerate kinase (Pgk1), the chaperones Ssa1
and Kar2, and the translocase Sec61 (Figure 2A).
The TOM complex was analyzed by blue native electropho-
resis upon lysis of mitochondria with digitonin. The levels of the
TOM complex were strongly reduced after the 24 hr shift of
ck2-ts cells to nonpermissive conditions (Figure 2B). Inner-
membrane complexes such as supercomplexes of the respira-
tory chain (complexes III and IV) and the ATP synthase (complex
V) were not or were only moderately affected (Figure 2C). We
conclude that inactivation of CK2 causes a reduction of the
amount of TOM complexes.
Tom22 Is Quantitatively Phosphorylated by CK2 in Yeast
To analyze the phosphorylation of Tom22 in a homologous
system, we incubated isolated yeast mitochondria with yeast
cytosolic extract in the presence of [g-33P]ATP. Phosphorylated
Tom22 was only observed in the autoradiography when mito-
chondria had been dephosphorylated by alkaline phosphataseCell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc. 229
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Figure 3. Tom22 Is Quantitatively Phos-
phorylated by CK2 in Yeast
(A) Yeast mitochondria were treated with alkaline
phosphatase (AP) as indicated and were sub-
jected to phosphorylation by yeast cytosolic
extract, followed by SDS-PAGE and autoradiog-
raphy.
(B) Mitochondria of Tom22 phosphomutant strains
were treated with AP, lysed, and analyzed by
Phos-tag SDS-PAGE and immunoblotting.
(C) Mitochondria were treated with AP, incubated
with cytosolic extract, and analyzed by SDS-PAGE
and immunoblotting.
(D) Phosphorylation of Tom22cd
WT with cytosolic
extract.
(E) Phosphorylation of Tom20cd
WT with cytosolic
extract.
See also Figure S2.(AP) before the incubation with cytosolic extract (Figure 3A,
lanes 4–6), suggesting that wild-type mitochondria contained
Tom22 in the phosphorylated state. Phosphorylation of Tom22
was inhibited on mitochondria that were isolated from a yeast
strain expressing the Tom22S44,46A mutant form (Figure 3A),
demonstrating that Ser44/46 is the major site of Tom22 phos-
phorylation in organello. For an independent analysis, we used
phosphate-affinity (Phos-tag) SDS-PAGE that retards the gel
mobility of the phosphorylated forms of proteins (Kinoshita
et al., 2006). Treatment of wild-type mitochondria with AP led
to a quantitative mobility shift of Tom22 detected with a holo-
Tom22 antibody (Figure 3B). In contrast, no shift was observed
with Tom22S44,46A mutant mitochondria; the mutant Tom22
migrated at the position of dephosphorylated Tom22. The
single-mutant forms Tom22S44A and Tom22S46A migrated
between the phosphorylated and dephosphorylated wild-type
species and were shifted to the faster-migrating form by AP
treatment (Figure 3B). Together with the observation that the
Ser44/46-containing peptides of Tom22 were consistently
observed in the doubly phosphorylated form by MS/MS
(Table S1 and Extended Experimental Procedures), these
results demonstrate that mitochondrial Tom22 is quantitatively
phosphorylated at Ser44 and Ser46.230 Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc.A cytosolic extract prepared from
ayeast strain lackingCka2, thea0 catalytic
subunit of CK2, was strongly impaired in
the phosphorylation of Ser46 on both
AP-treated mitochondria (Figure 3C) and
purified Tom22cd (Figure 3D). A cytosolic
extract prepared from a yeast strain that
lacked the other catalytic subunit, Cka1,
was able to phosphorylate Tom22cd (Fig-
ure 3D). For comparison, the phosphory-
lation of Ser172 of Tom20 was strongly
impaired with cka1D as well as cka2D
cytosolic extracts (Figure 3E), indicating
a differential dependence of Tom22 and
Tom20 phosphorylation on the catalytic
subunits of CK2. As control, cytosolicextracts prepared from yeast strains lacking other cytosolic
kinases like the MAPK Fus3, Snf1 (the yeast homolog of AMP-
dependent protein kinase), or Psk2 (a PAS domain-containing
kinase) were competent in phosphorylation of Tom22 and
Tom20 (Figures 3D and 3E).
To probe for an interaction of Tom22 with CK2, we performed
a pull-down assay with tagged Tom22cd. Cka1 and Cka2 were
found in the eluate when wild-type yeast cytosol was used (Fig-
ure S2A). However, both catalytic subunits were lacking in the
eluate when cka2D cytosolic extract was used, although the
extract contained wild-type levels of Cka1 (Figure S2A), indi-
cating that the CK2 complex interacts with Tom22 via Cka2.
The yield of Cka2 pull-down by Tom22 was influenced by the
ability of Tom22 to be phosphorylated; the mutant form
Tom22cd
S44,46A bound Cka2 with lower efficiency, and similarly,
addition of ATP to the binding buffer to complete the phosphor-
ylation reaction decreased the interaction of Tom22 with Cka2
(Figure S2B).
Phosphorylation of Tom22 Promotes Its Import
and Association with Tom20
Yeast mutant cells expressing Tom22S44,46A instead of wild-type
Tom22 from the endogenous promoter contained reduced
ED
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Figure 4. Phosphorylation of Tom22 by CK2 Promotes Import and Assembly
(A) Western blot of whole-yeast extract from Tom22WT and Tom22S44,46A strains grown from a stationary preculture to early/mid exponential growth phase at
30C.
(B) Western blot analysis of whole-yeast extract from Tom22WT and Tom22S44,46A strains grown in the presence or absence of cycloheximide (CHX). Quantifi-
cation: the Tom22 level at CHX addition (t = 0 hr) was set to 100% for each growth condition. Data are represented as mean ± SEM (n = 3).
(C) Tom22WT and Tom22S44,46A precursors were synthesized in reticulocyte lysate, treated with AP, and analyzed by Phos-tag SDS-PAGE and autoradiography.
(D) Transport of Tom22WT and Tom22S44,46A tomitochondria fromWT, tom20D, tom22D, and tom70D yeast strains. Analysis by SDS-PAGE and autoradiography.
(E) (Left) Blue native electrophoresis and immunoblot analysis of Tom22WT and Tom22S44,46A mitochondria. (Middle and right) Assembly of [35S]Tom20 into the
TOM complex of Tom22WT and Tom22S44,46A mitochondria, followed by treatment with AP as indicated. Analysis by blue native electrophoresis and digital
autoradiography (quantification: control WT values set to 100%).
See also Figure S3.steady-state levels of the receptor (Figure 4A) (the antibody used
recognized wild-type and mutant Tom22 with the same effi-
ciency; Figure S3A). Possible explanations for reduced levels
of Tom22 may be an impaired biogenesis or a faster turnover
of the mutant protein. To test the second possibility, protein
synthesis in the yeast cells was blocked by cycloheximide, and
the half-life of Tom22WT and Tom22S44,46A was compared.
Despite the lower protein level of Tom22S44,46A, the rate of
degradation was indistinguishable between mutant and wild-
type protein (Figure 4B).
Tom22 is synthesized on cytosolic ribosomes and posttransla-
tionally imported into mitochondria. We synthesized and 35S
labeled the precursor in reticulocyte lysate (lackingmitochondria).
Treatment with AP quantitatively shifted Tom22WT on Phos-tag
SDS-PAGE, whereas themobility of Tom22S44,46A was not altered
by AP yet the mutant protein migrated like AP-treated Tom22WT
(Figure 4C). We conclude that the precursor of Tom22 is quantita-tively phosphorylated at Ser44/46 in the cytosol.We incubated ra-
diolabeled Tom22 precursor with isolated mitochondria and
observed that the association of Tom22S44,46A with mitochondria
was of lower efficiency compared to Tom22WT (Figure 4D). To test
which Tom receptor was critical for the import of phosphorylated
Tom22 precursor into mitochondria, we used mitochondria from
yeast strains lacking Tom20, Tom22, or Tom70. tom20D mito-
chondria were impaired in import of phosphorylated Tom22WT,
and the difference in import efficiency of Tom22WT and
Tom22S44,46A became much smaller than with wild-type mito-
chondria (Figure 4D, top). In contrast, tom22D and tom70D
mitochondria showed the same difference in the efficiency of im-
porting Tom22WT and Tom22S44,46A as wild-type mitochondria
(Figure 4D), indicating that these mutant mitochondria discrimi-
nated between phosphorylated and nonphosphorylated Tom22
precursors. We conclude that the receptor Tom20 is required
for recognition and efficient import of phosphorylated Tom22.Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc. 231
Thus, phosphorylation of the Tom22 precursor stimulates its tar-
geting to mitochondria.
As the levels of Tom20 were reduced in ck2-ts mutants (Fig-
ure 2A), we asked whether the phosphorylation of Tom20 was
required for its biogenesis. Phos-tag gel analysis of yeast mito-
chondria, however, revealed that only a very minor fraction of
Tom20 molecules was phosphorylated in contrast to Tom22
(Figure S3B, lane 1). Only upon incubation with CK2 was a larger
fraction of mitochondrial Tom20 phosphorylated at residue
Ser172 (Figure S3B). We generated yeast mutant strains that ex-
pressed Tom20S172A or Tom20S172E (phosphomimetic glutamate)
instead of wild-type Tom20 yet did not observe any difference in
the protein composition of the resultingmitochondria (Figure S3C).
Import of the precursors of Tom20S172A and Tom20S172E intomito-
chondria was indistinguishable from that of wild-type Tom20, as
analyzed by binding to mitochondria and insertion into the
membranes (treatment with Na2CO3 at pH 11.5) (Figure S3D) and
assembly into the TOM complex (Figure S3E) (in lanes 4–6 of
Figure S3E, the wild-type precursor of Tom20 was treated with
CK2, yet the assembly of Tom20 was not affected). Mutant mito-
chondria carrying Tom20S172A or Tom20S172E imported precursor
proteins with wild-type efficiency both via the presequence
pathway and via the carrier pathway (Figures S3F and S3G).
Thus, mitochondrial Tom20 is phosphorylated by CK2 only to
a low level, and replacement of the phosphorylated residue neither
affects biogenesis of Tom20 nor import of precursor proteins.
Because the phosphorylation status of Tom20 itself was not
responsible for the reduced levels of Tom20 in ck2-ts cells, we
asked whether the phosphorylation status of Tom22 affected
the biogenesis of Tom20. The interaction between Tom22 and
Tom20 is involved at two different stages of biogenesis of the
TOM complex: (1) mature Tom20 functions as receptor for the
precursor of Tom22, and (2) though targeting of the precursor
of Tom20 to mitochondria does not require surface receptors,
the subsequent assembly of Tom20 into the TOM complex
depends on the interaction with Tom22 (Meisinger et al., 2001).
Blue native analysis of the TOM complex from a yeast strain con-
taining Tom22S44,46A revealed a double band (Figure 4E, lane 1),
the lower bandmigrating like a TOM complex that lacked Tom20
(Meisinger et al., 2001). We synthesized the precursor of Tom20
and imported it into mitochondria. Mitochondria from the
Tom22S44,46A yeast strain were indeed impaired in the assembly
of Tom20 into the TOM complex (Figure 4E). Remarkably, when
wild-type mitochondria with assembled Tom20 were treated
with AP after the import reaction, the association of Tom20
with the TOM complex was strongly reduced (Figure 4E, lane
12). In Tom22S44,46A mitochondria, the amount of Tom20 found
on the TOM complex was already at the low level that was not
further affected by dephosphorylation (Figure 4E).
Taken together, these results show that phosphorylation of
Tom22 at Ser44/46 plays a dual role: it not only stimulates target-
ing of Tom22 to mitochondria, but also the association of Tom20
with the TOM complex.
Phosphorylation of Mim1 by CK2 Is Required for the
Biogenesis of Tom Proteins
Import andassembly of the third import receptor, Tom70,wasnot
affected in Tom22S44,46A mitochondria (Figure 5A), although the232 Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc.levels of Tom70were reduced inck2-ts yeastmutants (Figure 2A).
Mitochondria isolated from ck2-ts yeast were impaired in the
assembly of the Tom70 precursor (Figure 5B, lanes 7–9)
(Tom70 is only loosely associated with the TOM complex and
migrates as dimer on blue native gels; Becker et al., 2008). Import
of the precursor of Tom70 does not require TOM receptors but
depends on the outer-membrane protein Mim1 (Becker et al.,
2008). We thus asked whether the levels of Mim1 were affected
in ck2-ts yeast cells. Upon a short 8 hr shift of ck2-ts cells to
nonpermissive temperature, the levels of Mim1 were partially
reduced, similar to the levels of Tom22 (Figure 5C). After a 16 hr
shift, the levels of Mim1 were strongly reduced (Figure 5C).
Two high-confidence phosphorylation sites were predicted in
Mim1, Ser12 and Ser16, both closely matching the CK2
consensus sequence (Meggio and Pinna, 2003). On Phos-tag
gels, mitochondrial Mim1 migrated in two distinct bands that
shifted to a single faster-migrating band upon treatment with
AP (Figure 5D). We generated a yeast strain in which both
Ser12 and Ser16 were replaced by alanine; the resulting
Mim1S12,16A migrated as a single band and was not further
affected by AP. Replacement of either Ser12 or Ser16 by alanine
led to bands with intermediate mobility that were sensitive to
treatment with AP (Figure 5D). We conclude that mitochondrial
Mim1 is phosphorylated at Ser12 and Ser16.
We tested the in vitro phosphorylation of the N-terminal domain
of Mim1 fused to GST using the purified kinases CK1, CK2, PKA
and CamKII. CK2 efficiently phosphorylated the Mim1 fusion
protein in a site-specific manner (Ser12/Ser16) (Figure 5E). In
a homologous yeast system, wild-type cytosolic extract phos-
phorylated the Mim1 fusion protein on Ser12/16 (Figure 5F). A
cytosolic extract lacking Cka2 did not phosphorylate Mim1,
whereas cka1D cytosol and mutants of further kinases phosphor-
ylated Mim1 with wild-type efficiency (Figure 5F). Phos-tag gel
analysis revealed that the precursor of Mim1 synthesized in retic-
ulocyte lysate was partially phosphorylated at Ser12/16 (Fig-
ure 5G), indicating that full phosphorylation of Mim1 occurred at
mitochondria. Taken together, we conclude that Mim1 is phos-
phorylated by CK2, mainly by the catalytic subunit Cka2.
We analyzed the biogenesis of Tom receptors in Mim1S12,16A
mutant mitochondria. The assembly of the precursor of Tom70
was impaired (Figure 5H). Assembly of Tom20 into the TOM
complex was also reduced in Mim1S12,16A mitochondria (Fig-
ure 5H). In contrast, the assembly of Tom22 into the TOM
complex was not affected in the Mim1S12,16A mitochondria (Fig-
ure 5H), in agreement with the Mim1-independent biogenesis of
Tom22 (Becker et al., 2008). Thus, replacement of the CK2 target
sites Ser12/16 of Mim1 impairs biogenesis of the receptors
Tom70 and Tom20.
Inactivation of CK2 Causes Defects of the Main
Mitochondrial Protein Import Pathways
Do the defects of the TOM complex in ck2-tsmutant cells lead to
an impairmentof themainmitochondrial protein importpathways?
To directly determine the capacity of mitochondria for importing
precursor proteins, we used the in organello import assay with
radiolabeled precursor proteins (Stojanovski et al., 2007).
Precursorproteinsdestined for the twomajormitochondrial import
pathways were analyzed: (1) presequence pathway into the
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Figure 5. Phosphorylation of Mim1 by CK2 Promotes Import of Tom70 and Tom20
(A) Assembly of [35S]Tom70 into Tom22WT and Tom22S44,46A mitochondria analyzed by blue native electrophoresis.
(B) Import and assembly of [35S]Tom70 into WT and ck2-ts mitochondria. Quantification by digital autoradiography (control WT value [lane 3] set to 100%).
(C) Levels of mitochondrial proteins of WT and ck2-ts yeast cells grown at 24C or shifted to 37C for 8–16 hr. Analysis by SDS-PAGE and immunoblotting.
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Figure 6. Inactivation of CK2 Causes Defects in Mitochondrial Protein Import
(A) WT and ck2-ts yeast cells were grown at 24C and shifted to 37C for 24 hr. [35S]F1bwas imported into mitochondria (Dc, membrane potential). Mitochondria
were treated with proteinase K and analyzed by SDS-PAGE. p, precursor; m, mature. Quantifications are shown as mean ± SEM (n = 3). Import into WT
mitochondria after the longest import time was set to 100% (control).
(B) Import of [35S]Su9-DHFR was performed as described in (A).
(C) Import of [35S]AAC was analyzed by blue native electrophoresis; quantification as in (A).matrix: F1-ATPase subunit b and the model precursor Su9-DHFR,
consisting of a mitochondrial presequence and the passenger
protein dihydrofolate reductase (Stojanovski et al., 2007) and (2)
carrier pathway into the innermembranewith the ADP/ATP carrier
(AAC) as major substrate (Wiedemann et al., 2001; Dolezal et al.,
2006; Neupert and Herrmann, 2007). All three precursor proteins
were efficiently imported in amembrane potential (Dc)-dependent
manner in ck2-ts mitochondria under permissive conditions
(Figures 6A–6C). Upon shift of the mutant cells to nonpermissive
temperature for 24 hr, the resulting mitochondria were strongly
impaired in import of the different precursor proteins (Figures
6A–6C). We conclude that the inactivation of CK2 leads to major
defects in the biogenesis of mitochondrial proteins, both for the
presequence pathway and the carrier pathway.
PKA Phosphorylates Mitochondrial Tom70 under
Fermentable Conditions
To study the phosphorylation of Tom70 in vivo, we generated an
antiserum that selectively recognized phospho-Ser174 and234 Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc.observed a specific signal of mitochondrial Tom70 from wild-
type yeast, but not from mutant yeast in which Ser174 was re-
placed by alanine (Figure 7A, lanes 1 and 2).
PKA is a heterotetramer composed of two catalytic subunits
and two regulatory subunits. In yeast, the closely related genes
TPK1, TPK2, and TPK3 encode the catalytic subunits, and
BCY1 encodes the regulatory (inhibitory) subunit (Zaman et al.,
2008). Binding of cAMP to Bcy1 releases the active catalytic
subunits. Yeast cytosolic extract phosphorylated the cytosolic
receptor domain of yeast Tom70 at Ser174; H89 that inhibits
the catalytic subunits of PKA blocked the phosphorylation (Fig-
ure 7B, top). When cytosolic extract with a low phosphorylating
activity was used, the PKA activator 8Br-cAMP stimulated the
phosphorylation of Tom70cd (Figure 7B, middle). Cytosolic
extract from a yeast mutant in which the catalytic subunits
were inactivated (mutant form of TPK3 and deletion of TPK1
and TPK2) was strongly impaired in phosphorylation of Tom70
(Figure 7B, bottom). Yeast PKA is activated on fermentable
medium, whereas the PKA activity is low under nonfermentable
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Figure 7. Phosphorylation of Tom70 by Protein Kinase A Impairs Carrier Import
(A) WT and mutant yeast strains were grown on fermentable medium, and mitochondria were isolated and treated with PKA as indicated. Analysis by SDS-PAGE
and western blotting.
(B) Phosphorylation of Tom70cd with yeast cytosolic extract, analyzed by immunoblotting. (Lanes 1–6) Cytosolic extract of WT yeast (grown on YPD) treated with
the PKA inhibitor H89 as indicated. (Lanes 7–12) Cytosolic extract of WT yeast (grown on YPG) supplemented with 8Br-cAMP as indicated. (Lanes 13–18)
Cytosolic extracts of WT and PKA mutant yeast strains (grown on YPD), supplemented with 8Br-cAMP.
(C) (Left) Cytosolic extract of WT yeast grown on YPD or YPG was incubated with Tom70cd or Kemptide-GST in presence of [g-
33P]ATP. (Right) WT yeast
cells grown on YPG were incubated with glucose for 15 min as indicated before preparation of cytosolic extract, which was used for phosphorylation of
Tom70cd.
(D) [35S]AAC and PiC were incubated with Tom70WT, Tom70S174A, and Tom70S174E mitochondria. Mitochondria were treated with proteinase K, lysed with
digitonin, and analyzed by blue native electrophoresis (quantification: control WT values [lanes 7 and 19] set to 100%).
(E) [35S]AAC was incubated with isolated mitochondria under ATP-depleted conditions, followed by treatment with proteinase K (Prot. K) as indicated. The
samples were analyzed by blue native electrophoresis.
(F) Assembly of [35S]AAC into WT mitochondria in the presence of soluble Tom70cd
WT (mg) that was phosphorylated by PKA prior to the import reaction as
indicated. Data are represented as mean ± SEM (n = 4). Assembly in the absence of Tom70cd was set to 100%.
(G) Pull-down from cytosolic extract of WT yeast cells with His10-tagged Tom70cd
WT that was pretreated with PKA as indicated. Ssa1, Pgk1, and Bmh1: 5%
of load, 100% of ATP-elution; Tom70 and Tom70pS174: 5% of load, 5% of imidazole-elution. Data are represented as mean ± SEM (n = 5); values without
PKA were set to 100%.
(H) WT (rho+), bcy1D, and WT rho yeast strains were grown on fermentable medium, and mitochondria were analyzed by SDS-PAGE and immunoblotting.
mg, mitochondrial protein loaded. See also Figure S4.conditions (Zaman et al., 2008), shown in Figure 7C for the phos-
phorylation of Tom70cd and the PKA model substrate Kemptide.
MS analyses detected phospho-Ser174 containing peptides of
mitochondrial Tom70 only from cells grown on fermentable
medium, but not from cells grown on nonfermentable medium
(Chi et al., 2007; Albuquerque et al., 2008; Extended Experi-
mental Procedures).The phospho-Ser174 signal observed after growth of yeast on
glucose (Figure 7A, lane 2) was strongly increased when the iso-
lated mitochondria were treated with PKA (Figure 7A, lane 3),
indicating that only a fraction of the Tom70 molecules had
been phosphorylated at Ser174 in vivo. The total mitochondrial
levels of Tom70, detected with Tom70-holo antiserum, were
not altered by its phosphorylation status (Figure 7A). Thus, alsoCell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc. 235
on a fermentable medium, only a fraction of Tom70 molecules
were phosphorylated.
Phosphorylation of Tom70 Impairs Import
of Mitochondrial Metabolite Carriers
For a functional analysis, we first askedwhether phosphorylation
of Tom70 influenced its targeting to mitochondria. We synthe-
sized the Tom70 precursor in reticulocyte lysate and analyzed
its targeting and membrane integration (resistance to extraction
at pH 11.5). When Ser174 was replaced by alanine or the phos-
phomimetic residue glutamate, targeting and membrane inser-
tion of Tom70 were not affected (Figure S4A); the blue native
mobility of the Tom70 dimer and the TOM complex were also
not altered (Figure S4B). These results indicate that neither tar-
geting of Tom70 to mitochondria nor the oligomeric state of
the TOM machinery was altered by the replacement of Ser174.
We thus asked whether the replacement of Tom70-Ser174
influenced the import of precursor proteins into mitochondria.
Tom70 functions as a main receptor for noncleavable hydro-
phobic precursors, including the AAC, phosphate carrier (PiC),
and dicarboxylate carrier (DIC) of the inner membrane (Neupert
and Herrmann, 2007; Chacinska et al., 2009). Import and
assembly of the 35S-labeled carrier proteins to themature dimers
can be monitored by blue native electrophoresis (Wiedemann
et al., 2001). Mutant mitochondria containing a glutamate
instead of Tom70-Ser174 were impaired in import of the carrier
proteins, whereas the replacement of Ser174 by alanine
enhanced their import (Figure 7D and Figure S4C). To exclude
indirect effects of the Tom70 mutants on mitochondrial protein
biogenesis, we used two precursor proteins that are not im-
ported by the Tom70-carrier pathway (Chacinska et al., 2009):
the presequence-carrying model preprotein b2-DHFR that is
transported to the inner membrane in a Dc-dependent manner
and the precursor of Tim9 that is transported into the intermem-
brane space. Both precursor proteins were efficiently imported
into the Tom70-Ser174 mutant mitochondria (Figures S4D and
S4E). These results indicate that replacement of Tom70-Ser174
by a phosphomimetic residue diminishes the efficiency of
protein import via the carrier pathway, whereas replacement
by a nonphosphorylatable residue enhances the import effi-
ciency. In wild-typemitochondria, a fraction of Tom70molecules
is phosphorylated, leading to an intermediate import efficiency.
The in organello binding of carrier precursors to Tom70 can be
visualized by blue native electrophoresis when [35S]AAC is accu-
mulated at the outer membrane of mitochondria upon depletion
of ATP (Wiedemann et al., 2001). The precursor proteins are
observed in high molecular mass complexes in a Tom70-depen-
dent manner and are accessible to externally added protease
(Figure 7E). Replacement of Tom70-Ser174 by alanine enhanced
the binding, whereas the replacement by glutamate diminished
the binding (Figure 7E). To obtain further evidence that the phos-
phorylation status of Tom70 is important for precursor binding,
we used a competition assay with the soluble cytosolic receptor
domain. Tom70cd added to in organello import assays has been
shown to bind AAC precursors and thus to compete with their
import into mitochondria (Brix et al., 2000). The wild-type form
of recombinant Tom70cd, which is not phosphorylated upon
synthesis in E. coli, competed with AAC import into mitochon-236 Cell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc.dria, as did recombinant Tom70cd
S174A (Figure S4F). The phos-
phomimetic mutant form Tom70cd
S174E did not affect the import
of AAC (Figure S4F). To obtain direct evidence that phosphoryla-
tion of Tom70 by PKA impairs precursor binding, we phosphor-
ylated Tom70cd by PKA before the competition assay. Indeed,
PKA-treated Tom70cd did not compete for the import of AAC,
in contrast to nonphosphorylated Tom70cd (Figure 7F).
Carrier proteins are delivered to Tom70 in a complex with the
cytosolic chaperone Hsp70 that specifically binds to Tom70
(Young et al., 2003). Ser174 is located in close proximity to the
Hsp70-binding pocket of Tom70 (Li et al., 2009). As the nega-
tively charged C-terminal EEVD motif of Hsp70 is involved in
binding to Tom70 (Li et al., 2009), we hypothesized that introduc-
tion of negative charge by phosphorylation might interfere with
Hsp70 binding. We incubated yeast cytosol with tagged
Tom70cd and observed binding of Hsp70 (Ssa1) to the receptor,
but not of control proteins like Pgk1 or Bmh1 (Figure 7G). Phos-
phorylation of Tom70cd by PKA diminished the binding of Ssa1 to
Tom70 (Figure 7G). We conclude that PKA-mediated phosphor-
ylation of Tom70 at Ser174 impairs the activity of the receptor for
binding of Hsp70 and import of carrier precursors.
In yeast lacking the regulatory subunit Bcy1, the activity of
PKA is not controlled anymore by cAMP levels. bcy1D cells are
unable to grow on nonfermentable medium (Zaman et al.,
2008). We compared the levels of mitochondrial proteins from
bcy1D cells to that of wild-type cells. The levels of TOM proteins,
as well as of Mim1 and the control matrix protein Hsp60, were
not or were only moderately affected in bcy1D cells (Figure 7H).
However, the levels of AAC and PiC were considerably
decreased in bcy1D cells (Figure 7H). To exclude that decreased
levels of carrier proteins were a general phenotype of strains that
cannot grow on nonfermentable medium, we also analyzed
mitochondrial protein levels of a rho strain that lacks functional
mitochondrial DNA (but contains the subunits of PKA). The levels
of the carrier proteins in the rho cells were close to that of the
rho+ cells (Figure 7H). In agreement with the in organello studies,
the in vivo results indicate that activation of PKAexerts a negative
effect on the levels of mitochondrial metabolite carriers.
DISCUSSION
The TOM complex is essential for the import of most mitochon-
drial proteins from the cytosol. Though numerous studies have
investigated the cytosolic-mitochondrial network in apoptosis
and information on the regulation of mitochondrial morphology
is increasing (Desagher et al., 2001; Pagliarini and Dixon, 2006;
Soubannier and McBride, 2009), little has been known about
the regulation of mitochondrial protein import, and posttransla-
tional regulatory mechanisms acting at the preprotein translo-
cases of the mitochondrial membranes have been unknown.
We report that the TOM complex is targeted by cytosolic
kinases. CK2 and PKA differentially regulate biogenesis and
function of the TOM complex and thus control mitochondrial
protein homeostasis.
CK2 plays important roles in the regulation of numerous
cellular processes, including gene expression, cell-cycle
progression, cell polarity, and ion homeostasis; roles of CK2 in
protection from apoptosis and phosphorylation of enzymes
involved in mitochondrial lipid metabolism have also been re-
ported (Hanna et al., 1995; Desagher et al., 2001; Meggio and
Pinna, 2003; Onorato et al., 2005; Poole et al., 2005; Tripodi
et al., 2010). We found that CK2 phosphorylates two key compo-
nents required for the biogenesis of the TOM complex, Tom22
and Mim1, and thus ck2 mutant yeast cells contain strongly
reduced levels of the TOM complex. (1) The precursor of
Tom22 is quantitatively phosphorylated by CK2 in the cytosol.
Phosphorylation of Ser44/46 stimulates targeting of the
precursor to mitochondria. The mechanistic basis is that the
interaction of Tom22 with its import receptor Tom20 is enhanced
by the phosphorylation. The phosphorylation-stimulated interac-
tion of Tom22 and Tom20 serves a dual function in TOM biogen-
esis: it is not only required for importing the precursor of Tom22,
but also for the assembly of imported Tom20 into the TOM
complex. (2) The outer-membrane protein Mim1 is not a struc-
tural part of the TOM complex but transiently interacts with the
complex and is required for the import of several Tom proteins,
including the precursors of Tom70, Tom20, and small Tom
proteins, but not for the import of Tom22 (Chacinska et al.,
2009). CK2 efficiently phosphorylates Mim1, and the levels of
Mim1 are reduced in ck2mutant yeast. Mitochondria containing
a mutant form of Mim1 that cannot be phosphorylated by CK2
are impaired in the import of Tom70 and Tom20.
Taken together, CK2 controls the biogenesis of all TOM recep-
tors: Tom22 by direct phosphorylation, Tom70 via phosphoryla-
tion of Mim1, and Tom20 via Mim1 and Tom22. The strong
reduction in the levels of all three TOM receptors, in turn, leads
to further defects, of particular importance being the biogenesis
of the import channel Tom40 that involves all three receptors,
Tom20, Tom22, and Tom70 (Chacinska et al., 2009). The low
TOM levels then cause major defects in mitochondrial biogen-
esis, including the main protein import pathways, presequence
pathway and carrier pathway, that strictly depend on the TOM
complex. CK2 is constitutively active, though its activity for
specific substrates may be modulated by a regulation of copy
number, subcellular localization, conformational changes, and
interaction partners (Poole et al., 2005). It has been observed
that the activity of CK2 is higher in rapidly growing cells, both
inmammals and yeast, i.e., under conditions in whichmoremito-
chondria are needed (Meggio and Pinna, 2003; Tripodi et al.,
2010). By phosphorylation of Tom22 and Mim1, CK2 plays an
important stimulatory role in the biogenesis of the TOM complex.
CK2 thus controls the levels of themainmitochondrial entry gate,
suggesting a role of CK2 in promoting biogenesis of
mitochondria.
In contrast to the stimulatory role of CK2 on mitochondrial
biogenesis, PKA impairs the receptor activity of Tom70. Addition
of glucose to yeast cells leads to an activation of this cAMP-
dependent protein kinase (Zaman et al., 2008). PKA has been
found in association with different cell organelles and has been
found to affect mitochondrial morphology, oxidative metabo-
lism, and apoptosis; cAMP-dependent phosphorylation of
a few nuclear-encoded proteins was shown to modulate their
interaction with Hsp70 chaperones and transfer into mitochon-
dria (Robin et al., 2003; Pagliarini and Dixon, 2006; de Rasmo
et al., 2008; Soubannier and McBride, 2009). The identification
of Tom70 as a target of PKA reveals that PKA not only affectsmitochondrial import via phosphorylation of a small set of
precursor proteins, but also exerts a direct regulatory effect on
the TOM machinery. Phosphorylation of Tom70 by PKA impairs
its receptor activity by diminishing the interaction with cytosolic
Hsp70 and the import of hydrophobic precursors such as the
inner-membrane metabolite carriers. On nonfermentable
medium, cells depend on respiration, and thus a high activity
of mitochondria is required, including an increased need for
exchange of metabolites between mitochondria and the rest of
the cell. Under these conditions, Tom70 is not phosphorylated
by PKA and can exert its full receptor activity. When shifting to
growth on glucose (fermentable medium), metabolite exchange
between mitochondria and the rest of the cell is diminished,
and fewer metabolite carrier proteins are needed; a fraction of
Tom70 molecules becomes phosphorylated and is impaired in
the import of metabolite carriers. The phosphorylation by PKA
thus serves as a regulatory means to adjust the import rate of
metabolite carriers to the metabolic state of the cell.
In summary, the protein import machinery of themitochondrial
outer membrane is regulated by cytosolic kinases at several
levels, TOM biogenesis and receptor activity, and under different
growth conditions. The regulatory effects of CK2 and PKA on the
TOM receptors demonstrate that the main mitochondrial entry
gate for preproteins is not functioning autonomously but is
embedded into cellular signaling networks. These findings reveal
a posttranslational mechanism for controlling mitochondrial pre-
protein translocases.
EXPERIMENTAL PROCEDURES
Analysis of Yeast Strains
S. cerevisiae cells were grown on YPD (2% glucose), YPG (3% glycerol), or
synthetic medium (Trp; 3% glycerol) at 23C –37C. Mitochondria were iso-
lated by differential and gradient centrifugation. Yeast strains expressing
Tom22WT or Tom22S44,46A from the authentic promoter were inoculated from
an overnight preculture to an OD600nm of 0.1 in YPG and were grown at
30C. For analysis of protein turnover, cycloheximide (50 mg/ml) was added
3 hr after inoculation. YPH250 (parental strain), YDH6 (WT, cka1::HIS3
cka2::TRP1 + p(CEN6/ARSH4 LEU2 CKA2)), and YDH13 (ck2-ts, cka1::HIS3
cka2::TRP1 + p(CEN6/ARSH4 LEU2 cka2–13)) (Hanna et al., 1995) were inoc-
ulated to anOD600nm of 0.2 in YPG andwere grown for 2 hr at 24
C, followed by
an incubation at 24C or 37C for 24 hr. Samples were taken, and whole-cell
extracts were generated by precipitation with trichloroacetic acid or postalka-
line extraction and analyzed by SDS-PAGE and western blotting. See
Extended Experimental Procedures.
In Vitro and In Organello Phosphorylation
Substrate proteins were expressed in E. coli and were purified. In vitro phos-
phorylation with recombinant protein kinases (CK2, CK1, PKA, CamKII, p42
MAPK, CDK1-cyclinB, CDK2-cyclinA, and GSK3; New England Biolabs) was
done in the presence of [g-33P]ATP (Perkin Elmer). For generation of cytosolic
extract, yeast cells were treated with zymolyase 20T and lysed with glass
beads; cell debris was removed by centrifugation, and the protein content
was adjusted by absorbance at 280 nm. The cytosolic extract was supple-
mented with ATP and mixed with recombinant protein or isolated mitochon-
dria. Phosphorylation was detected by digital autoradiography or western
blotting with phosphosite-specific antibodies.
Alkaline Phosphatase Treatment and Phosphate-Affinity SDS-PAGE
Mitochondria were resuspended in ST buffer (10 mM Tris/HCl [pH 7.2],
250 mM sucrose, 2 mM MgCl2, and 2 mM PMSF) to a protein concentration
of 1 mg/ml, and 1 U AP per 5 mg mitochondrial protein was added. SamplesCell 144, 227–239, January 21, 2011 ª2011 Elsevier Inc. 237
were incubated for 30 min at 25C and mild shaking. Mitochondria were
washed, lysed, and subjected to SDS-PAGE or Phos-tag electrophoresis (Ki-
noshita et al., 2006) on 12.5%–15% acrylamide gels containing 50–100 mM
Phos-tag and 100–200 mM MnCl2.
Protein Import Assays
[35S]Methionine-labeled precursor proteins were synthesized in rabbit reticulo-
cyte lysate, and levels were adjusted as necessary. Precursors were incubated
with isolated mitochondria in import buffer (250 mM sucrose, 80 mM KCl,
5 mMMgCl2, 2 mM KH2PO4, 5 mMmethionine, 3% (w/v) fatty acid-free bovine
serum albumin, and 10 mMMOPS/KOH [pH 7.2]) with 2 mM ATP and 2–3 mM
NADH (Stojanovski et al., 2007). Mitochondria were washed, treated with
proteinase K or Na2CO3, and analyzed by SDS-PAGE or blue native electropho-
resis and digital autoradiography. For competition assays (Brix et al., 2000), re-
combinant Tom70cd was phosphorylated with PKA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and one table and can be found with this article online at doi:10.
1016/j.cell.2010.12.015.
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